Dr Angel Wong
I am a pharmacoepidemiologist. I obtained my undergraduate degree in Public Health at the Chinese University of Hong Kong. Then I completed my PhD in Pharmacoepidemiology at the University of Hong Kong, focusing on the use of different observational study designs and methodologies to investigate the adverse cardiovascular effects of macrolide antibiotics. I have been awarded a British Heart Foundation fellowship to study drug-drug interactions using routine care data.
I am currently the co-director of the LSHTM Distance Learning and intensive Postgraduate Professional Development Course in Pharmacoepidemiology and Pharmacovigilance. I am also a tutor on the Basic Epidemiology module.
My main research area is pharmacoepidemiology, focusing on the use of different study designs and methodologies, including within-person study designs and propensity score method to address bias and confounding.
I currently hold a British Heart Foundation Immediate Postdoctoral Basic Science Research Fellowship for research studies investigating drug-drug interactions in the UK and Hong Kong. Since April 2020, I have been involved in OpenSAFELY platform to conduct studies focusing on the epidemiology of COVID-19. I am also collaborating with the University of Hong Kong to study drug effects using routine data from Hong Kong.